STOCKHOLM, Sweden--(BUSINESS WIRE)--Elekta (STO:EKTA) today announced a new order from India for Leksell Gamma Knife® Perfexion™, the world’s most advanced system for non-invasive radiosurgery of brain disorders including tumors, brain metastases and functional disorders. The purchase decision is an important step in the effort to improve quality and capacity of treatment of brain diseases for the entire northern part of India. The order also demonstrates that Elekta has earned a strong reputation in one of the most interesting emerging markets in the world as a company with state-of-the-art technology and clinical solutions for treatment of cancer and brain disorders.
